5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory,...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; por |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | JASMINE ELEANOR ZUNIC NICHOLAS SIMON STOCK JOHN HOWARD HUTCHINSON JEFFREY ROGER ROPPE MUSTAPHA HADDACH BRIAN ANDREW STEARNS JILLIAN F. EVANS YIWEI LI PETPIBOON PEPPI PRASIT JEANNIE M. ARRUDA MARK MORAN |
description | Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT1943219EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT1943219EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT1943219EE3</originalsourceid><addsrcrecordid>eNrjZDA21fXxDPCPiHR39XMMdtV1dA7xDHMM8fRzVwgI8g9x9fRT0HDzcQzQVPD08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASGGlibGRoaWrq7GRCgBAF-XJws</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS</title><source>esp@cenet</source><creator>JASMINE ELEANOR ZUNIC ; NICHOLAS SIMON STOCK ; JOHN HOWARD HUTCHINSON ; JEFFREY ROGER ROPPE ; MUSTAPHA HADDACH ; BRIAN ANDREW STEARNS ; JILLIAN F. EVANS ; YIWEI LI ; PETPIBOON PEPPI PRASIT ; JEANNIE M. ARRUDA ; MARK MORAN</creator><creatorcontrib>JASMINE ELEANOR ZUNIC ; NICHOLAS SIMON STOCK ; JOHN HOWARD HUTCHINSON ; JEFFREY ROGER ROPPE ; MUSTAPHA HADDACH ; BRIAN ANDREW STEARNS ; JILLIAN F. EVANS ; YIWEI LI ; PETPIBOON PEPPI PRASIT ; JEANNIE M. ARRUDA ; MARK MORAN</creatorcontrib><description>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111219&DB=EPODOC&CC=PT&NR=1943219E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111219&DB=EPODOC&CC=PT&NR=1943219E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JASMINE ELEANOR ZUNIC</creatorcontrib><creatorcontrib>NICHOLAS SIMON STOCK</creatorcontrib><creatorcontrib>JOHN HOWARD HUTCHINSON</creatorcontrib><creatorcontrib>JEFFREY ROGER ROPPE</creatorcontrib><creatorcontrib>MUSTAPHA HADDACH</creatorcontrib><creatorcontrib>BRIAN ANDREW STEARNS</creatorcontrib><creatorcontrib>JILLIAN F. EVANS</creatorcontrib><creatorcontrib>YIWEI LI</creatorcontrib><creatorcontrib>PETPIBOON PEPPI PRASIT</creatorcontrib><creatorcontrib>JEANNIE M. ARRUDA</creatorcontrib><creatorcontrib>MARK MORAN</creatorcontrib><title>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS</title><description>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDA21fXxDPCPiHR39XMMdtV1dA7xDHMM8fRzVwgI8g9x9fRT0HDzcQzQVPD08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASGGlibGRoaWrq7GRCgBAF-XJws</recordid><startdate>20111219</startdate><enddate>20111219</enddate><creator>JASMINE ELEANOR ZUNIC</creator><creator>NICHOLAS SIMON STOCK</creator><creator>JOHN HOWARD HUTCHINSON</creator><creator>JEFFREY ROGER ROPPE</creator><creator>MUSTAPHA HADDACH</creator><creator>BRIAN ANDREW STEARNS</creator><creator>JILLIAN F. EVANS</creator><creator>YIWEI LI</creator><creator>PETPIBOON PEPPI PRASIT</creator><creator>JEANNIE M. ARRUDA</creator><creator>MARK MORAN</creator><scope>EVB</scope></search><sort><creationdate>20111219</creationdate><title>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS</title><author>JASMINE ELEANOR ZUNIC ; NICHOLAS SIMON STOCK ; JOHN HOWARD HUTCHINSON ; JEFFREY ROGER ROPPE ; MUSTAPHA HADDACH ; BRIAN ANDREW STEARNS ; JILLIAN F. EVANS ; YIWEI LI ; PETPIBOON PEPPI PRASIT ; JEANNIE M. ARRUDA ; MARK MORAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT1943219EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JASMINE ELEANOR ZUNIC</creatorcontrib><creatorcontrib>NICHOLAS SIMON STOCK</creatorcontrib><creatorcontrib>JOHN HOWARD HUTCHINSON</creatorcontrib><creatorcontrib>JEFFREY ROGER ROPPE</creatorcontrib><creatorcontrib>MUSTAPHA HADDACH</creatorcontrib><creatorcontrib>BRIAN ANDREW STEARNS</creatorcontrib><creatorcontrib>JILLIAN F. EVANS</creatorcontrib><creatorcontrib>YIWEI LI</creatorcontrib><creatorcontrib>PETPIBOON PEPPI PRASIT</creatorcontrib><creatorcontrib>JEANNIE M. ARRUDA</creatorcontrib><creatorcontrib>MARK MORAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JASMINE ELEANOR ZUNIC</au><au>NICHOLAS SIMON STOCK</au><au>JOHN HOWARD HUTCHINSON</au><au>JEFFREY ROGER ROPPE</au><au>MUSTAPHA HADDACH</au><au>BRIAN ANDREW STEARNS</au><au>JILLIAN F. EVANS</au><au>YIWEI LI</au><au>PETPIBOON PEPPI PRASIT</au><au>JEANNIE M. ARRUDA</au><au>MARK MORAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS</title><date>2011-12-19</date><risdate>2011</risdate><abstract>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; por |
recordid | cdi_epo_espacenet_PT1943219EE |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A37%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JASMINE%20ELEANOR%20ZUNIC&rft.date=2011-12-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT1943219EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |